Health Canada approves Assure Tech Ecotest COVID-19 serological rapid test for COVID-19 – Verify Diagnostics

Verify Diagnostics announced that Health Canada has authorized the Assure Tech Ecotest COVID-19 serological rapid test to be used at the point-of-care (POC) for the purpose of screening for SARS-CoV-2 antibodies.

Building on the U.S. FDA Emergency Use Authorization (EUA) granted last year, Verify Diagnostics has worked diligently with Health Canada, since March 2020, to bring this test to Canada.

The Assure Tech Ecotest was the first point-of-care fingerstick blood test to be authorized for CLIA Waived use in the United States and is the first Canadian test to be authorized as well.